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Given the importance of G173 to the acyl chain length specificity of the E. coli LpxA, we made the reciprocal change to the P. aeruginosa enzyme, changing the methionine at the equivalent position, 169, to the E. coli residue, glycine. The M169G mutant prefers 3-OH-C14-ACP over 3-OH-C10-ACP (Table 1) .
We were interested in confirming the specificity reversals in vivo. E. coli strain RO138 (lpxA2 recA) 5 produces wild type lipid A (mass = 1797) when grown at 30°C, but at 42°C has little LpxA activity, produces very little lipid A, and dies rapidly. 7 However, the temperature-sensitivity of RO138 can be corrected by a plasmid copy of E. coli lpxA. If RO138 is covered with a plasmid copy of P. aeruginosa lpxA, the strain also survives at 42°C, but produces lipid A with a mass of 1685, corresponding to 3-OH-C10 at the 3 and 3′ positions. 6 We transformed RO138 with plasmids encoding the G173M and M169G mutant LpxAs. Both strains survive at 42°C. RO138/ pG173M produces lipid A with a mass of 1685, while RO138/pM169G produces lipid A with a mass of 1797. Thus, the same specificity reversal seen by in vitro assay can be demonstrated in living cells.
A single amino acid change (G173M) can reverse the acyl chain length specificity of E. coli LpxA by 10 6 -fold. The reciprocal change to the P. aeruginosa enzyme (M169G) reverses its specificity by 10 5 fold. The reversal can be demonstrated both in vitro and in vivo. The in vivo studies in strain RO138 suggest the possibility of using similar acyl chain length specificity mutants of other lipid A acyltransferases to produce biologically interesting lipid A analogs easily and efficiently in living cells.
Nitric oxide (NO) is a free radical messenger produced by NO synthases (NOS) from the precursor L-arginine. An inducible NOS (iNOS), whose expression is driven by inflammatory mediators, such as endotoxin, has been associated with the hypotension of septic shock. The vasodilatory effect of NO relies on the direct activation of soluble guanylate cyclase and is cGMP-dependent. NO also has an incompletely defined role in inflammation. The regulation of inflammatory responses by NO has implications for the use of NOS inhibitors in septic shock, and the administration of inhaled NO in acute respiratory distress syndrome. In a series of investigations, we have studied the regulation of tumor necrosis factor (TNFα) by NO.
First, we studied the effect of exogenous NO on LPSinduced TNFα production in human neutrophil preparations. 1 Human neutrophils exposed to LPS and INF-γ did not show measurable increases in intracellular cGMP. However, cGMP increased up to 30-fold (P <0.01) in neutrophils incubated with both the NO donor sodium nitroprusside (SNP) and N-acetylcysteine (NAC), a thiol that increases the bioavailability of NO. The increase in cGMP levels indicates that neutrophils contain a NO-sensitive guanylate cyclase. In the absence of LPS, SNP, with or without NAC, did not increase TNFα production in human neutrophils. However, LPS-dependent TNFα production was increased by SNP (P <0.05) and this effect was further augmented by the addition of NAC (P <0.02). INF-γ greatly increased LPS-induced TNFα production by human neutrophils (P < 0.01), but SNP plus NAC further increased TNFα production in these highly activated cells (P <0.001). The cell membrane permeable cGMP analog, dibutyryl cGMP (Bt 2 cGMP) did not increase TNFα production by neutrophils under any of the experimental conditions. These data suggest that NO increases TNFα production through a mechanism independent of cGMP. 1 To exclude possible nonspecific effects associated with exogenous NO sources, we transfected human monoblastoid U937 cells with an expression vector containing murine iNOS cDNA. 2 Western blot confirmed expression of iNOS protein in these cells, but not in naive or emptyvector transfected cells. Further, iNOS transfectants, but not empty-vector transfectants, spontaneously produced NO (P <0.001). A NOS inhibitor, N ω -methyl-L-arginine (L-NMA), blocked NO release from iNOS transfected cells, as measured by nitrite and nitrate accumulation (P <0.01). After differentiation with phorbol-12-myristate-13-acetate (PMA), iNOS transfectants retained the ability to release NO and produced more TNFα (124.9 ± 25.4 pg/5 x 10 5 cells per 24 h) than did empty-vector transfected cells (21.9 ± 1.9 pg/5 x 10 5 cells per 24 h; P = 0.02), an effect inhibited by 500 µM L-NMA (54.4 ± 3.1 pg/5 x 10 5 cells per 24 h; P = 0.05). These results showed that endogenously produced NO, like exogenous NO sources, can upregulate TNFα production in human phagocytes. 2 In the next investigation we sought to determine the cGMP-independent mechanism by which NO regulated TNFα production. 3 NO has been shown to inhibit adenylate cyclase in cell membrane preparations. Since cAMP is also known to reduce TNFα release, we tested the possibility that NO enhances TNFα production by decreasing intracellular cAMP levels. Like previous experiments, PMA (100 nM) was used to induce U937 cells to produce TNFα. Incubation of these cells with 500 µM SNP or Snitroso-N-acetylpenicillamine (SNAP) increased TNFα production by 7.0-and 15.6-fold, respectively (P = 0.002). This response, however, was completely unrelated to cGMP as these cells lack an NO-sensitive guanylate cyclase, and cGMP analogs had no effect on TNFα synthesis. In contrast, SNP and SNAP were both found to decrease basal and agonist-stimulated intracellular cAMP concentrations (P <0.01, for all). Furthermore, H89, an inhibitor of cAMP-dependent protein kinase, mimicked the effect of NO by dose dependently increasing TNFα production in the absence (6.5-fold at 30 µM; P = 0.04), but not in the presence of SNAP (P = 0.8). Conversely, a cell permeable cAMP analog, dibutyryl cAMP, blocked SNAP-induced increases in TNFα production and TNFα mRNA levels (P <0.01, for both). These results indicate that NO-induced upregulation of TNFα production in human phagocytes is dependent on decreases in intracellular cAMP. 3 Because cAMP is known to regulate promoter activity through both the cAMP response element (CRE) and Sp1 binding sites, the wild-type 1311-base pair human TNFα promoter was compared to CRE or Sp1 deletion mutants for responses to NO, H89, and dibutyryl cAMP. These experiments demonstrated that the Sp1 site mediated the upregulatory effect of NO and H89 on the TNFα promoter. 4 Collectively, this series of investigations suggests the following conclusions: (i) NO upregulates TNFα gene transcription; (ii) this effect of NO is cGMPindependent and associated with decreases in intracellular cAMP; and (iii) the Sp1 binding site in the TNFα promoter functions as a NO-response element.
